Summary by Futu AI
On December 31, 2023, a Schedule 13G amendment was filed with the SEC by Intelligent Bio Solutions Inc., indicating a significant ownership stake by Lind Global Fund II LP, Lind Global Partners II LLC, and Jeff Easton. The filing, which is a regulatory requirement for parties owning more than five percent of a company's stock, shows that these entities and individual collectively hold 960,000 shares of Intelligent Bio Solutions' common stock, representing 9.9% of the company. The ownership consists of warrants to purchase common stock, but due to exercise limitations, the beneficial ownership is capped at 960,000 shares. Jeff Easton, as the managing member of Lind Global Partners II LLC and the general partner of Lind Global Fund II LP, is deemed to have sole voting and dispositive power over the shares held by Lind Global Fund II LP. The principal business office for all reporting persons is located at 444 Madison Ave, Floor 41, New York, NY 10022. The filing, dated February 13, 2024, includes a joint filing agreement among the reporting persons.
